Supplementary Table S1 from The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer

<p>Supplementary Table S1. List of Antibodies used</p>

Gardado en:

Detalles Bibliográficos
Autor Principal:	Megharani Mahajan (19810332) (author)
Outros autores:	Alondra L. Rodriguez Sanchez (22164781) (author), Sridharan Jayamohan (22164784) (author), Dileep K. Vijayan (22164787) (author), Jessica D. Johnson (22164790) (author), Huan Xie (17316659) (author), Yang Wang (22164793) (author), Dong Liang (15107744) (author), John R. Sanchez (14958717) (author), Panneerdoss Subbarayalu (22164796) (author), Manjeet K. Rao (14956450) (author), Ratna K. Vadlamudi (12394034) (author), Gangadhara R. Sareddy (14958741) (author), Hareesh B. Nair (22164799) (author), Suryavathi Viswanadhapalli (14958693) (author)
Publicado:	2025
Subjects:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Breast Cancer Cell Signaling Drug Targets Progression, Invasion & Metastasis
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares